Navigation Links
Sexual Function Affected by Stem Cell Transplant According to Long-Term Study
Date:9/18/2007

WASHINGTON, Sept. 18 /PRNewswire-USNewswire/ -- A long-term study found that a type of stem cell transplant used for patients with life-threatening diseases, such as leukemia and lymphoma, results in decreased sexual function and activity for recipients. Further, males are likely to recover from these changes over time, while the sexuality of female patients remains compromised. In addition, neither male nor female long-term cancer survivors regained levels of sexual activity and function equal to those of their peers who have not had cancer, according to a Blood First Edition Paper prepublished online today. Blood is the official journal of the American Society of Hematology.

"Survival without a sex life should not be what cancer survivors settle for or what health-care professionals consider a successful outcome of cancer treatment," stated lead study author, Karen Syrjala, PhD, co-director of the Survivorship Program at the Fred Hutchinson Cancer Research Center. "Sexual dysfunction in survivors of cancer needs to become a priority for research funding and a routine topic of discussion between doctors and their patients after cancer treatment."

In an allogeneic hematopoeitic stem cell transplantation, patients with diseases of the blood, bone marrow, or certain types of cancers receive an infusion of new stem cells from a sibling or tissue-matched unrelated donor to replace the damaged or destroyed cells in their bone marrow needed for the production of blood cells. Before the transplant, high-dose chemotherapy is administered to kill residual cancer cells and to suppress the immune system so that the patient's body will not reject the new tissue.

The results of questionnaires on sexual function were reported for 161 patients scheduled to receive this procedure at the Fred Hutchinson Cancer Research Center in Seattle. The patients ranged in age from 22-64 years with an average age of 41 and a nearly even split by gender.

Before the
'/>"/>

SOURCE American Society of Hematology
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Palatin Technologies and King Pharmaceuticals Report Data Showing Improvements in Sexual Relationship and Self-Esteem in Patients with Erectile Dysfunction Treated with Bremelanotide
2. An Investigational Study Released at ADA Showed that Initial Combination Therapy with Januvia (sitagliptin) and Metformin Led to Improvement in Markers of Beta Cell Function in Patients with Type 2 Diabetes
3. Research Documents Scalable Production, Survival Following Engraftment and Positive Impact on Cardiac Function in Infarcted Rats for Gerons Human Embryonic Stem Cell-Based Therapeutic for Heart Failure
4. Data Showing that ReGens Colostrinin Supports Healthy Cognitive Function Presented at the 2007 International Congress on Natural Medicine in Australia
5. Data Suggest Cymbalta Improved Functioning in Patients with Generalized Anxiety Disorder
6. Palatin Technologies and King Pharmaceuticals Announce Plan To Present Results of Bremelanotide Phase 2b Studies in Men With Erectile Dysfunction
7. Early Results of the CellCept Spare the Nephron Study Examine Kidney Function
8. Revolutionary Immunologic Data Explains Function of Diamyd Diabetes Vaccine
9. EPIX Pharmaceuticals Announces Statistically Significant Results in Cognitive Function from Phase 1b Clinical Trial of Novel 5-HT6 Drug Candidate
10. Pharmacyclics Identifies Functional Biomarkers for its Novel HDAC Inhibitor and Demonstrates Preclinical Anti-Tumor Activity with Brutons Tyrosine Kinase Inhibitors
11. Ceregene Presents Long Term Follow-Up Data From Phase 1 Trial of CERE-120 Demonstrating Improved Motor Function in Parkinsons Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/9/2008)...paign to Spread Awareness and Bring Hope to Millio...swire-USNewswire/ -- 133 million children,across t...uch as natural,disaster, civil war, and disease. S...World Orphan Week by calling attention to the need...ews Release, go to:, http://www.prnewswire.com/m...
(Date:10/9/2008)...nal Science Institute, Navigenics, Affymetrix and,...N DIEGO, Oct. 9 /- A consortium of he...ined forces in a first-of-its-kind,research study ...c testing,on people who choose to receive such scr...oping certain diseases., Sponsored by Scripps Tra...
(Date:10/8/2008)...eday Inform Treatments for Spinal Cord, Other Nerv...Newswire/ -- A protein that enables,nerve cells to...ontrolling,the developing nervous system. Research...o form among nerve cells may provide a basis for e...s to their nervous system,including spinal cord i...
(Date:10/8/2008)...am to evaluate TAXUS(R) Element(TM) Platinum Chrom..., Mass., Oct. 8 /- Boston S...d that it has completed enrollment in,the PERSEUS ...neration,TAXUS(R) Element(TM) paclitaxel-eluting c...rolled nearly 1,500 patients at 100 U.S. and,inter...
Breaking Medicine Technology:Photos: SOS Children's Villages Observes World Orphan Week, October 5-11, 2008 2Landmark Research Study is Launched to Assess Impact of Personal Genetic Testing 2Landmark Research Study is Launched to Assess Impact of Personal Genetic Testing 3Landmark Research Study is Launched to Assess Impact of Personal Genetic Testing 4Landmark Research Study is Launched to Assess Impact of Personal Genetic Testing 5Protein Shown to Play a Key Role in Normal Development of Nervous System 2Protein Shown to Play a Key Role in Normal Development of Nervous System 3Boston Scientific Completes Clinical Trial Enrollment for Third-Generation Drug-Eluting Stent 2Boston Scientific Completes Clinical Trial Enrollment for Third-Generation Drug-Eluting Stent 3Boston Scientific Completes Clinical Trial Enrollment for Third-Generation Drug-Eluting Stent 4Your belly fat could be making you hungrier 17023 1Your belly fat could be making you hungrier 17023 2GHX Introduces NuVia 28TM 29 an Artificial Intelligence based Technology That Enables a New Approach to Content Management for Healthcare Providers 17020 1GHX Introduces NuVia 28TM 29 an Artificial Intelligence based Technology That Enables a New Approach to Content Management for Healthcare Providers 17020 2GHX Introduces NuVia 28TM 29 an Artificial Intelligence based Technology That Enables a New Approach to Content Management for Healthcare Providers 17020 3The Miracle of Funding by State and Local Pension Plans 17016 1The Miracle of Funding by State and Local Pension Plans 17016 2AegisLiving Partners With Technogym USA to Enhance Wellness Throughout Its Communities 17012 1AegisLiving Partners With Technogym USA to Enhance Wellness Throughout Its Communities 17012 2AegisLiving Partners With Technogym USA to Enhance Wellness Throughout Its Communities 17012 3
...WIRE)--Jun 1, 2007 - OXiGENE, Inc.,(NASDAQ: OXGN, ...mpany developing novel therapeutics to treat cance...n of two abstracts in the,2007 Annual Meeting prog...ng of the American Society of Clinical Oncology (A...or the first time full data from a,randomized Phas...
... 2007 /PRNewswire-FirstCall/ -- Kosan,Biosciences ...se 2,monotherapy trial showing that tanespimycin d... patients with metastatic melanoma,including one ...d,prior chemotherapy (within 6 weeks of initiation...on-free survival for more than,six months and 20% ...
Other Medicine Technology:OXiGENE Abstracts Published in ASCO Program 2OXiGENE Abstracts Published in ASCO Program 3OXiGENE Abstracts Published in ASCO Program 4Kosan Presents Preliminary Phase 2 Data Showing Antitumor Activity,of Hsp90 Inhibitor Tanespimycin in Metastatic Melanoma at ASCO 2Kosan Presents Preliminary Phase 2 Data Showing Antitumor Activity,of Hsp90 Inhibitor Tanespimycin in Metastatic Melanoma at ASCO 3Kosan Presents Preliminary Phase 2 Data Showing Antitumor Activity,of Hsp90 Inhibitor Tanespimycin in Metastatic Melanoma at ASCO 4
(Date:10/10/2008)... BEDFORD, Mass., Oct. 10 /PRNewswire-FirstCall/...loper, manufacturer and supplier of premium,diagno...ts dedicated to,serving the healthcare needs of wo...uarter and fiscal 2008 operating results on Tuesda...ction with the release, management will,host a con...
(Date:10/10/2008)... PARK CITY, Utah, Oct. 10 /PRNewswire/ -- NuVie... management of Trace Life Sciences Inc.,(Trace), i...cyclotron,production facilities in Denton, Texas. ... Indium-111, Iodine-123 and Thallium-201 used in,m... NuView Chairman and,CEO, stated that "We are conf...
(Date:10/10/2008)... Coach Holly Warlick Teams Up with Legal and Me...rst-Ever Cancer and Careers Seminar in,Knoxville, ...gnition of National,Breast Cancer Awareness Month,... have joined forces with YWCA Knoxville, The Welln...ocate Holly Warlick, University of Tennessee,women...
(Date:10/10/2008)... The Healthcare Technolog...Care , Exton, PA (PRWEB) ...Valley Chapters of the national Healthcare Informa...ned forces to bring regional health information te...onal conference entitled The Healthcare Technology...
Breaking Medicine News(10 mins):Health News:Hologic, Inc. To Release Fourth Quarter and Fiscal 2008 Operating Results on Tuesday, November 11, 2008 2Health News:Local Experts Help Women Living and Working with Cancer Even the Score 2Health News:Local Experts Help Women Living and Working with Cancer Even the Score 3Health News:Local Experts Help Women Living and Working with Cancer Even the Score 4Health News:HIMSS New Jersey and Delaware Valley Chapters Sponsor Regional Conference 2
...test mysteries that has been plaguing mankind is t... have finally been able to unravel the mystery wit...y scientists after a study of more than 1000 peopl...eed to be answered on a scale of 1 to 10 and the s...
...by researchers in the Institute of Preventive Medi...asionally may be beneficial in countering dementia...that people who drank wine weekly or monthly were ...ia, said that the findings are important because t...
...earchers of the Harvard Medical School, of more th...amine antagonists, i.e. anti-psychotics, for eithe... have an increased risk of breast cancer. The stud... taking dopamine antagonists and 55,000 women who ...
...ished in an online issue of Nature Medicine by res... a stunning discovery of a bold new type of vaccin...gs. The study which was carried// out on monkeys s...med and adapted in humans may signal a major new t...
Other Medicine News:Health News:The Happiness Formula.... 2
...a national reference laboratory and a worldwide le...ment. ARUP offers an extensive test menu of highly...anatomic pathology. Owned by the University of Uta...lf of the nation's university teaching hospitals a...
...a national reference laboratory and a worldwide le...ment. ARUP offers an extensive test menu of highly...anatomic pathology. Owned by the University of Uta...lf of the nation's university teaching hospitals a...
...a national reference laboratory and a worldwide le...ment. ARUP offers an extensive test menu of highly...anatomic pathology. Owned by the University of Uta...lf of the nation's university teaching hospitals a...
...a national reference laboratory and a worldwide le...ment. ARUP offers an extensive test menu of highly...anatomic pathology. Owned by the University of Uta...lf of the nation's university teaching hospitals a...
Medicine Products: